Investigational Site Number 724002

Madrid 28046

0 studies enrolling now · 6 studies all time

What they study most

Ankylosing Spondylitis, Hematopoietic Neoplasm, Hypercholesterolemia, Neoplasm Malignant, Prostate Cancer, Venous Thromboembolism

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis — Completed
• First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor — Completed
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer — Completed
• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed